Template:Neuroendocrine tumors: Difference between revisions
Jump to navigation
Jump to search
Sara Mohsin (talk | contribs) No edit summary |
No edit summary |
||
(11 intermediate revisions by 2 users not shown) | |||
Line 10: | Line 10: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Neuroendocrine tumors# | [[Neuroendocrine tumors# Patient Information|Patient Information]] | ||
|- | |- | ||
! | ! | ||
Line 16: | Line 16: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Neuroendocrine tumors# | [[Neuroendocrine tumors #Overview|Overview]] | ||
|- | |- | ||
! | ! | ||
Line 22: | Line 22: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Neuroendocrine tumors#Historical | [[Neuroendocrine tumors#Historical Perspective|Historical Perspective]] | ||
|- | |- | ||
! | ! | ||
Line 46: | Line 46: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Neuroendocrine tumors#Natural | [[Neuroendocrine tumors#Epidemiology and Demographics|Epidemiology and Demographics]] | ||
|- | |||
! | |||
|- bgcolor="Pink" | |||
! | |||
[[Neuroendocrine tumors#Risk factors|Risk factors]] | |||
|- | |||
! | |||
|- bgcolor="Pink" | |||
! | |||
[[Neuroendocrine tumors#Natural History, Complications and Prognosis|Natural History, Complications and Prognosis]] | |||
|- | |- | ||
! | ! | ||
Line 52: | Line 63: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Neuroendocrine tumors#History and | [[Neuroendocrine tumors#History and Symptoms|History and Symptoms]] | ||
|- | |- | ||
! | ! | ||
Line 58: | Line 69: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Neuroendocrine tumors#Laboratory | [[Neuroendocrine tumors#Laboratory Findings|Laboratory Findings]] | ||
|- | |- | ||
! | ! | ||
Line 64: | Line 75: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Neuroendocrine tumors#CT|CT]] | [[Neuroendocrine tumors#CT scan|CT scan]] | ||
|- | |- | ||
! | ! | ||
Line 70: | Line 81: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Neuroendocrine tumors#PET|PET]] | [[Neuroendocrine tumors#PET scan|PET scan]] | ||
|- | |- | ||
! | ! | ||
Line 76: | Line 87: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Neuroendocrine tumors#Medical | [[Neuroendocrine tumors#Medical Therapy|Medical Therapy]] | ||
|- | |- | ||
! | ! | ||
Line 88: | Line 99: | ||
|- | |- | ||
|} | |} | ||
<noinclude> | |||
<templatedata> | |||
{ | |||
"params": {} | |||
} | |||
</templatedata> | |||
</noinclude> |
Latest revision as of 07:44, 13 November 2019
Neuroendocrine tumors Microchapters |
<templatedata> { "params": {} } </templatedata>